Total Payments
$1,906
2024 Payments
$319.01
Companies
15
Transactions
89
Medicare Patients
5,826
Medicare Billing
$495,192
Payment Breakdown by Category
Food & Beverage$1,892 (99.3%)
Education$13.89 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,892 | 88 | 99.3% |
| Education | $13.89 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $858.94 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $204.52 | 12 | $0 (2024) |
| Insmed, Inc. | $167.36 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $131.25 | 5 | $0 (2024) |
| La Jolla Pharmaceutical Company | $113.64 | 1 | $0 (2018) |
| Mallinckrodt LLC | $101.75 | 1 | $0 (2017) |
| United Therapeutics Corporation | $75.63 | 3 | $0 (2024) |
| Pulmonx Corporation | $55.04 | 3 | $0 (2023) |
| Boston Scientific Corporation | $45.28 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $38.25 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.01 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.21) |
| 2023 | $280.46 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($136.50) |
| 2022 | $41.29 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28.56) |
| 2021 | $64.45 | 3 | United Therapeutics Corporation ($27.39) |
| 2020 | $123.65 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($53.00) |
| 2019 | $556.81 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($244.52) |
| 2018 | $326.34 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($159.72) |
| 2017 | $194.18 | 6 | Mallinckrodt LLC ($101.75) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: LUX-Dx_CRM | ||||||
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | Breas Medical, Inc. | Vivo 45 LS (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/11/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: LUX-Dx_CRM | ||||||
| 02/27/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: PULMONOLOGY | ||||||
| 09/05/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: PAH | ||||||
| 08/16/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/01/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: RESPIRATORY | ||||||
| 05/11/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug), OFEV | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,351 | 1,660 | $589,073 | $123,133 |
| 2022 | 16 | 1,526 | 1,782 | $553,144 | $121,202 |
| 2021 | 15 | 1,403 | 1,597 | $516,131 | $115,297 |
| 2020 | 16 | 1,546 | 1,885 | $598,005 | $135,560 |
Total Patients
5,826
Total Services
6,924
Medicare Billing
$495,192
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 400 | $121,938 | $39,039 | 32.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 49 | 88 | $112,288 | $15,876 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 217 | $43,597 | $15,726 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 125 | 125 | $54,625 | $15,459 | 28.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 41 | 74 | $32,338 | $7,200 | 22.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 146 | 162 | $32,562 | $7,121 | 21.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 146 | 162 | $33,048 | $6,643 | 20.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 138 | 154 | $55,132 | $3,100 | 5.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 18 | $7,272 | $2,519 | 34.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 77 | 82 | $64,616 | $2,438 | 3.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $7,015 | $1,994 | 28.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $9,410 | $1,919 | 20.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,665 | $1,295 | 77.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 37 | 40 | $6,760 | $999.72 | 14.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,674 | $615.99 | 36.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 37 | 41 | $4,018 | $589.95 | 14.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $675.00 | $568.08 | 84.2% |
| 94761 | Test to measure oxygen level in blood using ear or finger device multiple times | Office | 2023 | 11 | 11 | $440.00 | $28.80 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 302 | $83,645 | $29,698 | 35.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 93 | $107,880 | $17,860 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 129 | 129 | $51,213 | $17,091 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 200 | $36,548 | $13,682 | 37.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 240 | 259 | $47,397 | $12,132 | 25.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 243 | 261 | $48,285 | $11,364 | 23.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 249 | 271 | $88,075 | $5,743 | 6.5% |
About Dr. Sam Faradyan, M.D
Dr. Sam Faradyan, M.D is a Pulmonary Disease healthcare provider based in West Palm Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013076470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Faradyan, M.D has received a total of $1,906 in payments from pharmaceutical and medical device companies, with $319.01 received in 2024. These payments were reported across 89 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,892).
As a Medicare-enrolled provider, Faradyan has provided services to 5,826 Medicare beneficiaries, totaling 6,924 services with total Medicare billing of $495,192. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location West Palm Beach, FL
- Active Since 12/08/2006
- Last Updated 07/17/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013076470
Products in Payments
- OFEV (Drug) $564.61
- Arikayce (Drug) $167.36
- TRELEGY ELLIPTA (Drug) $146.58
- STIOLTO RESPIMAT (Drug) $135.08
- GIAPREZA (Drug) $113.64
- YUPELRI (Drug) $107.84
- ACTHAR (Biological) $101.75
- STIOLTO (Drug) $92.43
- TYVASO (Drug) $75.63
- SPIRIVA RESPIMAT (Drug) $66.82
- CHARTIS CATHETER (Device) $39.43
- AirFit (Device) $37.95
- ANORO (Drug) $37.22
- LUX-Dx Insertable Cardiac Monitor (Device) $32.55
- Yupelri (Drug) $23.41
- Vivo 45 LS (Device) $23.27
- SYMBICORT (Drug) $22.72
- ANORO ELLIPTA (Drug) $20.72
- Veklury (Drug) $20.39
- TUDORZA PRESSAIR (Drug) $17.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in West Palm Beach
Dr. Vijay Srinivasan, M.d, M.D
Pulmonary Disease — Payments: $585.23
Pulmonary Disease $585.23
Min Zhou, M.d, M.D
Pulmonary Disease — Payments: $123.96
Pulmonary Disease $123.96
Dr. Edward Klotz, M.d, M.D
Pulmonary Disease
Pulmonary Disease
Dr. Marius Figueredo, M.d, M.D
Pulmonary Disease
Pulmonary Disease
Mr. Swie The, Md, MD
Pulmonary Disease
Pulmonary Disease
Jonathan Gavras, Md, MD
Pulmonary Disease
Pulmonary Disease